US 8940301
Breast tumor treatment with anti-CXCR1 compositions
granted A61KA61K31/18A61K31/337
Quick answer
US patent 8940301 (Breast tumor treatment with anti-CXCR1 compositions) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/18, A61K31/337, A61K45/06, A61P